Home › Stocks › CLDX › All Fund Holders
CLDX — CELLDEX THERAPEUTICS INC NEW · All Fund Holders
Funds holding (latest): 40 · Reported value held: $1.31B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Wellington Management Group history | Q2 2026 | 9.54M | $355.12M | 0.07% | Add |
| BlackRock Inc history | Q2 2026 | 7.00M | $260.56M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.72M | $138.53M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 4.03M | $109.38M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 2.02M | $75.26M | 0.00% | Add |
| Viking Global Investors history | Q2 2022 | 2.34M | $63.03M | 0.30% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.62M | $60.11M | 0.01% | Add |
| Millennium Management history | Q2 2026 | 1.17M | $43.56M | 0.02% | Reduce |
| Northern Trust Corp history | Q2 2026 | 719.65K | $26.78M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 661.24K | $24.60M | 0.02% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 655.95K | $24.41M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 607.20K | $22.59M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 482.00K | $17.94M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 404.70K | $15.06M | 0.01% | Add |
| Marshall Wace history | Q3 2024 | 276.73K | $9.41M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 224.18K | $8.34M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 196.97K | $7.33M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 176.59K | $6.57M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 157.24K | $6.00M | 0.00% | New |
| Casdin Capital history | Q3 2022 | 165.00K | $4.64M | 0.30% | Hold |
| Point72 Asset Management history | Q2 2026 | 119.42K | $4.44M | 0.01% | Reduce |
| Invesco Ltd history | Q2 2026 | 103.13K | $3.84M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 89.34K | $3.32M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 86.89K | $3.23M | 0.00% | Add |
| Renaissance Technologies history | Q4 2025 | 118.49K | $3.22M | 0.01% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 78.18K | $2.91M | 0.00% | Add |
| Arrowstreet Capital history | Q3 2021 | 44.36K | $2.40M | 0.00% | New |
| Moore Capital Management history | Q4 2022 | 50.00K | $2.23M | 0.05% | Add |
| Legal & General Investment Management America history | Q2 2026 | 59.55K | $2.22M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 57.90K | $2.15M | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 26.31K | $979.11K | 0.00% | Reduce |
| CPP Investments history | Q4 2024 | 37.00K | $934.99K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 25.64K | $813.62K | 0.00% | Hold |
| Franklin Resources history | Q2 2023 | 23.00K | $780.49K | 0.00% | New |
| D. E. Shaw & Co history | Q2 2026 | 17.83K | $663.30K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 16.70K | $621.33K | 0.00% | Add |
| Principal Global Investors history | Q2 2024 | 10.57K | $391.27K | 0.00% | Reduce |
| Amundi US history | Q2 2026 | 9.35K | $347.95K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 4.69M | $174.34K | 0.02% | Add |
| PNC Financial Services history | Q2 2026 | 469 | $17.45K | 0.00% | Reduce |